Wednesday, May 15, 2019

Vertex to pay startup Kymera $70 million in R&D deal - STAT

Vertex to pay startup Kymera $70 million in R&D deal  STAT

Vertex Pharmaceuticals will pay $70 million up front to a Cambridge, Mass., startup that hopes to use a novel approach to treat diseases.



No comments:

Post a Comment

Note: Only a member of this blog may post a comment.